Organon & Co.
OGN
$6.37
$0.030.47%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -5.34% | 1.26% | -0.81% | -6.72% | -0.38% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.34% | 1.26% | -0.81% | -6.72% | -0.38% |
| Cost of Revenue | 6.47% | 11.23% | 6.29% | -0.30% | 1.90% |
| Gross Profit | -14.51% | -5.85% | -5.86% | -11.18% | -2.08% |
| SG&A Expenses | -6.10% | -1.66% | 3.66% | -2.55% | 18.60% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.71% | 3.36% | 3.03% | -2.40% | 6.73% |
| Operating Income | -20.52% | -5.13% | -12.95% | -19.32% | -22.08% |
| Income Before Tax | -214.73% | 17.39% | -2.55% | -57.20% | 24.04% |
| Income Tax Expenses | 185.00% | 154.61% | 110.00% | -60.00% | 104.52% |
| Earnings from Continuing Operations | -288.07% | -55.43% | -25.64% | -56.72% | -80.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -288.07% | -55.43% | -25.64% | -56.72% | -80.04% |
| EBIT | -20.52% | -5.13% | -12.95% | -19.32% | -22.08% |
| EBITDA | -11.46% | 0.65% | -5.97% | -12.73% | -15.42% |
| EPS Basic | -286.26% | -55.86% | -26.40% | -57.08% | -80.20% |
| Normalized Basic EPS | -31.54% | -2.11% | -22.79% | -22.91% | -38.92% |
| EPS Diluted | -291.42% | -55.80% | -25.63% | -57.69% | -80.66% |
| Normalized Diluted EPS | -30.95% | -1.51% | -22.46% | -23.04% | -39.22% |
| Average Basic Shares Outstanding | 0.96% | 0.96% | 1.03% | 0.85% | 0.81% |
| Average Diluted Shares Outstanding | 0.11% | 0.34% | 0.60% | 1.02% | 1.28% |
| Dividend Per Share | -92.86% | -92.86% | -92.86% | 0.00% | 0.00% |
| Payout Ratio | -1.03% | -0.91% | -0.83% | 1.34% | 4.08% |